CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
February 3, 2020
CVS Caremark’s newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging employers and plan sponsors to cheaper generic drugs, Fierce Healthcare reports.
According to the report, RxZERO allows sponsors to cover the entire tab for diabetes drugs while slashing costs and avoiding premium hikes.
“Eliminating out-of-pocket costs for diabetes medications ensures long-term affordability, improves adherence, and most importantly, puts patients on the path to better health,” CVS CMO Troy Brennan said in a statement.
To read the full report on Fierce Healthcare, click here.
